Trials / Recruiting
RecruitingNCT05541601
Prospective Cohort for Early Detection of Liver Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
This study aims to recruit 3000 people with liver cirrhosis into a Prospective cohort for early detection of Liver cancer - the Pearl cohort. The study team believe that using a combination of novel tests may improve the detection of early Hepatocellular Carcinoma (HCC).
Detailed description
During a four-year follow-up period, around 100 Pearl patients are expected to be diagnosed with HCC. Blood, urine, clinical and imaging data will be collected over the follow up period. The samples will be used to identify a range of tests (including genetic, protein and other biomarkers), which along with the clinical data will hopefully identify those most at risk of developing HCC, and to identify HCC at the earliest possible time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood and Urine samples | The samples will be used to identify a range of tests (including genetic, protein and other biomarkers), which along with the clinical data will hopefully identify those most at risk of developing HCC, and to identify HCC at the earliest possible time points. |
Timeline
- Start date
- 2022-02-23
- Primary completion
- 2037-07-01
- Completion
- 2037-07-01
- First posted
- 2022-09-15
- Last updated
- 2022-09-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05541601. Inclusion in this directory is not an endorsement.